High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.
Genital herpes is a sexually transmitted infection (STI) caused by herpes simplex virus 2 (HSV-2) and to a lesser extent herpes simplex virus 1 (HSV-1). Infection by HSV-2 is life-long and is associated with significant cost to healthcare systems and social stigma despite the highly prevalent nature...
Saved in:
Main Authors: | Sophia T Mundle, Hector Hernandez, John Hamberger, John Catalan, Changhong Zhou, Svetlana Stegalkina, Andrea Tiffany, Harry Kleanthous, Simon Delagrave, Stephen F Anderson |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/d67d7fbcea1545a78cf5d2f5c0f3bbb7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acta Nº529
by: Banco Central de Chile
Published: (2019) -
Immunogenicity of a DNA vaccine candidate for COVID-19
by: Trevor R. F. Smith, et al.
Published: (2020) -
A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.
by: Jan Balzarini, et al.
Published: (2013) -
Epistles of the Brethren of Purity
by: Sajjad Rizvi
Published: (2016) -
Epistles of the Brethren of Purity. On the Natural Sciences
by: Sajjad Rizvi
Published: (2014)